Insider Stock Trading History of Orbimed Capital Gp Iv Llc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Orbimed Capital Gp Iv Llc since year 2005. The trader's CIK number is 1502240. At the time of this reporting, Orbimed Capital Gp Iv Llc is the 10% Owner of Principia Biopharma Inc. . (stock ticker symbol PRNB). See this page for all insider trading activities at Principia Biopharma Inc. .

Note that in the past OrbiMed Capital GP IV LLC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Orbimed Capital Gp Iv Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-09-18 PRNB Principia Biopharma Inc. Buy 250,000 17.00 4,250,000
2018-03-08 BOLD Audentes Therapeutics, Inc. Sale 58,428 34.06 1,990,057
2018-03-12 BOLD Audentes Therapeutics, Inc. Sale 18,003 35.48 638,746
2018-03-09 BOLD Audentes Therapeutics, Inc. Sale 80,000 35.66 2,852,559
2018-03-06 BOLD Audentes Therapeutics, Inc. Sale 11,372 33.03 375,617
2018-03-05 BOLD Audentes Therapeutics, Inc. Sale 200 36.06 7,212
2018-03-02 BOLD Audentes Therapeutics, Inc. Sale 421,638 35.70 15,050,368

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Gp Iv Llc (10% Owner of Principia Biopharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.